Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

TSE:6144
TSE:6144Machinery

Asian Dividend Stocks To Consider In November 2025

As global markets navigate the complexities of economic shifts, including the recent end of the longest U.S. government shutdown, investors are turning their attention to Asia where mixed performances in China and Japan highlight both challenges and opportunities for growth. In this environment, dividend stocks present a compelling option for those seeking steady income streams amidst market volatility, as they often provide a cushion against uncertain economic conditions while offering...
PSE:NIKL
PSE:NIKLMetals and Mining

Asian Undervalued Small Caps With Insider Buying To Watch In November 2025

As global markets navigate a complex landscape marked by mixed performances in key indices and cautious monetary policies, the Asian market remains an area of interest for investors, particularly in the small-cap segment. With small-cap stocks often sensitive to economic shifts and interest rate movements, identifying those with potential value can be crucial; factors such as insider buying may offer additional insights into promising opportunities amidst these dynamic conditions.
TSE:7718
TSE:7718Machinery

Undiscovered Gems in Asia for November 2025

As the Asian markets navigate a landscape marked by fluctuating economic indicators and shifting investor sentiment, small-cap stocks have faced unique challenges and opportunities. With interest rate movements influencing market dynamics, particularly in sectors sensitive to such changes, identifying promising stocks requires a keen eye for potential growth amid broader market volatility. In this context, finding undiscovered gems involves looking beyond immediate headlines to assess...
NasdaqGS:CTKB
NasdaqGS:CTKBLife Sciences

Cytek Biosciences (CTKB): Evaluating Valuation After TIME's Growth Leaders 2026 Recognition

Cytek Biosciences (CTKB) is catching fresh attention after being named to TIME’s 2026 list of America’s Growth Leaders, a recognition that highlights the company’s momentum and strengths in cell analysis technology. See our latest analysis for Cytek Biosciences. After a standout mention on TIME's Growth Leaders list, Cytek’s share price has surged, up 39% in the last month and 35% over the past quarter, as excitement builds around its innovative tech and recognition is fueling fresh momentum...
NYSE:PSFE
NYSE:PSFEDiversified Financial

Paysafe (PSFE): Has the Recent Earnings Reset Changed the Value Story?

Paysafe (NYSE:PSFE) shares have come under fresh scrutiny after the company announced higher net losses for the third quarter and trimmed its full-year revenue and earnings guidance. Several analysts responded by lowering their outlooks in response to concerns over ongoing risks. See our latest analysis for Paysafe. This year’s momentum around Paysafe has turned sharply negative, with the stock’s latest price at $6.98 and a year-to-date share price return of -59.7%. Even with some highlights,...
TSX:DND
TSX:DNDSoftware

Is Dye & Durham's (TSX:DND) Push Into Digital Municipal Services Shaping Its Competitive Edge?

On November 10, 2025, Dye & Durham Limited announced the launch of Tax Certificates Online (TCOL) for the City of Hamilton, offering a secure digital platform for instantly accessing property tax certificates and replacing manual, paper-based processes. This move not only streamlines due diligence for property professionals but also expands Dye & Durham’s digital footprint across Ontario’s municipal sector, reflecting the company’s focus on workflow automation and customer support. We’ll now...
HLSE:TOKMAN
HLSE:TOKMANMultiline Retail

Tokmanni Group Oyj (HLSE:TOKMAN) Is Down 16.2% After Lowering 2025 Revenue Guidance and Withholding Dividend

Tokmanni Group Oyj recently reported its Q3 2025 earnings, highlighting 4% year-over-year revenue growth but also announcing a downward revision to its full-year revenue guidance, now forecasting between €1.71 billion and €1.75 billion. The company is prioritizing profitability improvements by expanding private label offerings, focusing on turning around the Dollarstore segment, and withholding a second dividend installment to fund future investments. Next, we explore how Tokmanni's lowered...
NasdaqGS:AVXL
NasdaqGS:AVXLBiotechs

Why Anavex Life Sciences (AVXL) Is Down After an EMA Setback for Its Alzheimer’s Drug Application

Anavex Life Sciences recently reported that the European Medicines Agency’s Committee for Medicinal Products for Human Use issued a negative trend vote on the company’s Marketing Authorisation Application for blarcamesine, an investigational oral treatment for early Alzheimer’s disease. This outcome prompts Anavex to seek a re-examination and submit additional biomarker data, while maintaining regulatory dialogue with both European and U.S. health authorities. We'll explore how this...